Huff James Warren - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 26, 2023, Huff James Warren's relationship to REATA PHARMACEUTICALS INC (RETA) is Director,Officer (Chief Executive Officer), and currently has 0 shares of Class A common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RETA insiders.

Data Source: SEC.
Huff James Warren - Insider Non-Derivative Transactions of RETA Class A common stock
Huff James Warren - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 27, 2023 Disposition -- (Class A common stock) 122480 0 0
Sep 27, 2023 Disposition -- (Class A common stock) 10398 0 0
Jul 7, 2023 Acquisition -- (Class A common stock) 11656 0 49916
Jul 7, 2023 Acquisition -- (Class A common stock) 72564 0 122480
Mar 3, 2023 Sell -- (Class A common stock) 570 91.12 36158
Mar 3, 2023 Sell -- (Class A common stock) 4623 90.57 36728
Mar 3, 2023 Sell -- (Class A common stock) 5742 89.49 41351
Mar 3, 2023 Sell -- (Class A common stock) 12826 88.59 47093
Mar 3, 2023 Sell -- (Class A common stock) 4034 87.61 59919
Mar 3, 2023 Sell -- (Class A common stock) 3475 86.44 63953
Mar 3, 2023 Sell -- (Class A common stock) 6395 85.25 67428
Mar 3, 2023 Sell -- (Class A common stock) 7439 84.33 73823
Mar 3, 2023 Sell -- (Class A common stock) 9660 83.31 81262
Mar 3, 2023 Sell -- (Class A common stock) 12132 82.2 90922
Mar 3, 2023 Sell -- (Class A common stock) 8104 81.49 103054
Mar 2, 2023 C -- (Class A common stock) 75000 0 111158
Jan 4, 2023 Acquisition -- (Class A common stock) 47025 0 47025